ArticleDrugs - real world outcomes2019

Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study.

Yukinori Sakata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.